Financial

DUBLIN, Aug. 20, 2018 /PRNewswire/ -- The "Minimally Invasive Surgical Instruments Market by Product, by Application, by End User, by Geography - Global Market Size, Share, Development, Growth, and Demand Forecast, 2016-2023" report has been added to ResearchAndMarkets.com's offering. Global minimally invasive surgical instruments market is forecasted to attain revenue of $53.1 billion by 2023.The growth led by growing geriatric population, surge in

New York, NY, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Cartilage Repair/Regeneration Market by Treatment Modality (Cell-Based and Non-Cell Based), by Treatment (Cartilage Replacement and Cartilage Repair), by Type (Fibro Cartilage, Hyaline Cartilage, and Elastic Cartilage), and by End-Use (Ambulatory Surgical Centers, Hospitals & Clinics, Surgical Centers, and

NEW YORK and CANTON, Mass., Aug. 17, 2018 /PRNewswire/ -- Avista Healthcare Public Acquisition Corp. (NASDAQ :AHPA ) ("AHPAC"), a publicly traded special purpose acquisition company, and Organogenesis Inc. ("Organogenesis" or the "Company"), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care, Surgical and Sports Medicine markets, today announced that

SUWANEE, Ga., Aug. 14, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) reported financial results for the three months ended June 30, 2018 with the SEC on Tuesday, August 14, 2018 and will provide a business update on a conference call today, August 14, 2018 at 10:00 a.m. Eastern Time. Highlights of the second quarter and

(EMAILWIRE.COM, August 11, 2018 ) Artificial Disc Market  to exceed USD 4.5 billion by 2024 as per a new research report. Steadily growing number of osteoarthritis and rheumatoid arthritis procedures around the world is a primary factor responsible for artificial disc market growth. Increasing incidences of degenerative disc diseases and adult patient’s willingness to opt for artificial

AMSTERDAM, The Netherlands, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ:WMGI) today reported financial results for its second quarter ended July 1, 2018 and increased its 2018 annual guidance.  Unless otherwise noted, all net sales growth rates in this release are stated on a constant currency basis. Net sales totaled $205.4 million during

WALTHAM, Mass., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX), a leader in the development of restorative cell therapies (RCTs) that may offer rapid-onset pain relief and restored function, announced its financial and operating results for the quarter ended June 30, 2018. “Our focus in the second quarter of 2018 was on

WARSAW, Ind., Aug. 08, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today its financial results for the second quarter ended June 30, 2018. Second Quarter & Recent Highlights Increased total revenue to $15.1 million for second quarter 2018, up 27.7% from $11.8 million in second

BELGRADE, MT, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American:XTNT), a leader in the development of regenerative medicine products and medical devices, today reported financial and operating results for the second quarter ended June 30, 2018. Summary of Second Quarter 2018 Financial Highlights and Recent Announcements: Revenue for the second quarter of

August 07, 2018 CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) today provided a business update and reported financial results for the quarter ended June 30, 2018. Richard Toselli, M.D., President and Chief Executive Officer of InVivo, commented, “We continued to make progress in the second quarter of 2018, as the net proceeds of $13.5 million from